Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease
- PMID: 23038404
- PMCID: PMC4527158
- DOI: 10.1159/000343281
Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease
Abstract
Background: This study evaluates the prevalence of cardiovascular events in autosomal dominant polycystic kidney disease (ADPKD) patients.
Methods: We distributed surveys to 1,439 subjects from our ADPKD research database. In total, 426 subjects completed and returned surveys; 7 of these were from children and were excluded from the study.
Results: The patients who responded were female (63.2%), nonHispanic (88.1%) and white (93.6%). The mean age of the total group was 53.2 ± 13.7 years; 82.8% had a family history of ADPKD and 32.5% had reached end-stage renal disease (ESRD). With respect to cardiovascular risk factors, 86.6% were hypertensive with a mean age at diagnosis of 36.9 ± 12.9 years and hypertension was significantly more prevalent in males. In addition, 19.6% of the subjects were obese, 20.8% were smokers, 8.7% had diabetes, 45.7% had high cholesterol and 17.8% were sedentary. The most prevalent self-reported cardiovascular events were arrhythmias (25.9%), evidence of peripheral vascular disease (16.5%), heart valve problems (14.4%), cardiac enlargement (9.5%), stroke or cerebral bleeding (7.5%), myocardial infarction (6%) and brain aneurysm (5.0%). The most commonly used antihypertensive medications were renin-angiotensin inhibitors used by 75% of ADPKD patients. Older ADPKD patients and those at ESRD had a significantly higher incidence of cardiovascular events.
Conclusion: These findings support the high prevalence of cardiovascular risk factors and events in ADPKD patients which contribute to a greater mortality risk. Due to the prevalence of cardiovascular risk factors in the ADPKD population, early diagnosis and clinical intervention are recommended.
Copyright © 2012 S. Karger AG, Basel.
Conflict of interest statement
Similar articles
-
Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective.Clin Exp Nephrol. 2022 Jul;26(7):659-668. doi: 10.1007/s10157-022-02200-5. Epub 2022 Feb 25. Clin Exp Nephrol. 2022. PMID: 35212882
-
Clinical Manifestation, Management and Prognosis of Acute Myocardial Infarction in Autosomal Dominant Polycystic Kidney Disease.Kidney Blood Press Res. 2018;43(6):1806-1812. doi: 10.1159/000495638. Epub 2018 Nov 30. Kidney Blood Press Res. 2018. PMID: 30504716
-
An association between autosomal-dominant polycystic kidney disease and the risk of acute myocardial infarction in Asian population - results of a nationwide study.Oncotarget. 2017 Mar 21;8(12):19365-19375. doi: 10.18632/oncotarget.14269. Oncotarget. 2017. PMID: 28038444 Free PMC article.
-
Cardiovascular complications in autosomal dominant polycystic kidney disease.Curr Hypertens Rev. 2013 Feb;9(1):2-11. doi: 10.2174/1573402111309010002. Curr Hypertens Rev. 2013. PMID: 23971638 Review.
-
Update on pathogenesis, management, and treatment of hypertension in autosomal dominant polycystic kidney disease.Saudi J Kidney Dis Transpl. 2017 Mar-Apr;28(2):253-260. doi: 10.4103/1319-2442.202774. Saudi J Kidney Dis Transpl. 2017. PMID: 28352004 Review.
Cited by
-
Effect of Early and Delayed Commencement of Paricalcitol in Combination with Enalapril on the Progression of Experimental Polycystic Kidney Disease.J Cardiovasc Dev Dis. 2021 Oct 29;8(11):144. doi: 10.3390/jcdd8110144. J Cardiovasc Dev Dis. 2021. PMID: 34821697 Free PMC article.
-
Autosomal Dominant Polycystic Kidney Disease: From Pathogenesis to Organoid Disease Models.Biomedicines. 2025 Jul 18;13(7):1766. doi: 10.3390/biomedicines13071766. Biomedicines. 2025. PMID: 40722835 Free PMC article. Review.
-
The Impact of Autosomal Dominant Polycystic Kidney Disease in Children: A Nephrological, Nutritional, and Psychological Point of View.Biomedicines. 2024 Aug 12;12(8):1823. doi: 10.3390/biomedicines12081823. Biomedicines. 2024. PMID: 39200287 Free PMC article. Review.
-
Decreased Polycystin 2 Levels Result in Non-Renal Cardiac Dysfunction with Aging.PLoS One. 2016 Apr 15;11(4):e0153632. doi: 10.1371/journal.pone.0153632. eCollection 2016. PLoS One. 2016. PMID: 27081851 Free PMC article.
-
Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease.BMC Nephrol. 2014 Apr 16;15:63. doi: 10.1186/1471-2369-15-63. BMC Nephrol. 2014. PMID: 24739095 Free PMC article.
References
-
- McCullough PA. Scope of cardiovascular complications in patients with kidney disease. Ethn Dis. 2002;12:44–48. - PubMed
-
- U.S. Renal Data System. USRDS 2011 Annual Data Report. 2011
-
- Schrier RW. Optimal care of autosomal dominant polycystic kidney disease patients. Nephrology (Carlton) 2006;11:124–130. - PubMed
-
- Florijin KW, Noteboom WM, Van Saase JL, Chang PC, Breuning MH, Vandenbroucke JP. A century of mortality in five large families with polycystic kidney disease. Am J Kidney Dis. 1995;25:370–374. - PubMed